Differential sleep effects of eszopiclone treatment and discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder (MDD) or generalized anxiety disorder (GAD)

被引：0
|
作者：
Fava, M. [1 ]
Schaefer, K. [3 ]
Rockett, C. B. [4 ]
Amato, D. [3 ]
Roth, T. [2 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Henry Ford Sleep Disorders Ctr, Detroit, MI USA
[3] Sepracor Inc, Marlborough, MA USA
[4] GlaxoSmithKline Inc, Durham, NC USA
来源：
JOURNAL OF SLEEP RESEARCH | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [31] Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia
    Pollack, Mark
    Kinrys, Gustavo
    Roth, Thomas
    Rubens, Robert
    Schaefer, Kendyl
    Krystal, Andrew
    McCall, W. Vaughn
    Roach, Jim
    Huang, Holly
    Krishnan, Ranga
    [J]. NEUROLOGY, 2007, 68 (12) : A154 - A154
  • [32] Pharmacological treatment for insomnia in patients with major depressive disorder
    Brietzke, Elisa
    Vazquez, Gustavo H.
    Kang, Melody J. Y.
    Soares, Claudio N.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (11) : 1341 - 1349
  • [33] Insomnia and Sleep Duration in a Large Cohort of Patients With Major Depressive Disorder and Anxiety Disorders
    van Mill, Josine G.
    Hoogendijk, Witte J. G.
    Vogelzangs, Nicole
    van Dyck, Richard
    Penninx, Brenda W. J. H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (03) : 239 - 246
  • [34] Effects of eszopiclone co-therapy with escitalopram on measures of anxiety and mood outcomes in patients with insomnia and comorbid generalized anxiety disorder
    Pollack, M.
    Rubens, R.
    Amato, D.
    Schaefer, K.
    Pfleeger, K.
    Hayduk, R.
    Roth, T.
    [J]. SLEEP, 2007, 30 : A330 - A330
  • [35] Polysomnographic features of insomnia occurring in major depressive disorder, generalized anxiety disorder and bipolar mania: Comparison with primary insomnia and association with metabolic indicators
    Xu, Xiyu
    Wang, Qianjin
    Zhang, Zhuoran
    Jiao, Ziqiao
    Ouyang, Xuan
    Tao, Haojuan
    Zhao, Yixin
    Guo, Huili
    Liu, Tieqiao
    Tan, Liwen
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 351 : 449 - 457
  • [36] Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder
    Shigetsura, Yuki
    Imai, Satoshi
    Endo, Hiroki
    Shimizu, Yumi
    Ueda, Keita
    Murai, Toshiya
    Itohara, Kotaro
    Nakagawa, Shunsaku
    Yonezawa, Atsushi
    Ikemi, Yasuaki
    Fukatsu, Sachio
    Kitada, Noriaki
    Terada, Tomohiro
    Nakagawa, Takayuki
    Matsubara, Kazuo
    [J]. CLINICAL NEUROPHARMACOLOGY, 2022, 45 (03) : 52 - 60
  • [37] Validation of the sleep impact scale in patients with major depressive disorder and insomnia
    Lasch, Kathryn
    Joish, Vijay N.
    Zhu, Yueping
    Rosa, Kathleen
    Qiu, Chunfu
    Crawford, Bruce
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (07) : 1699 - 1710
  • [38] Safety of quetiapine for treatment of insomnia in patients with major depressive disorder
    Lee, S.
    Han, J. H.
    Hong, S. C.
    Jeong, J. H.
    Seo, H. J.
    Lim, H. K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S377 - S378
  • [39] Effects of foot reflexology on insomnia in patients with major depressive disorder
    Pratoomsri, Wetid
    Jariyaprayuklert, Kuntalee
    Poonnnotok, Rodjana
    Aeamla-Or, Napaporn
    [J]. ASEAN JOURNAL OF PSYCHIATRY, 2008, 9 (01): : 14 - 19
  • [40] Efficacy of pregabalin in elderly patients with generalized anxiety disorder (GAD) and with high levels of insomnia
    Montgomery, S.
    Xu, Y.
    Schweizer, E.
    Donevan, S.
    Lyndon, G.
    Prieto, R.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 29 - 30
12345